Publication | Closed Access
Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients
49
Citations
27
References
2012
Year
Hematological MalignancyTransplantationMarrow TransplantationOncologyMyeloablative AllograftImmunologyHematologyLenalidomide MaintenanceRefractory/relapsed Myeloma PatientsBlood TransplantationImmunotherapyMedicineCell TransplantationGraft Rejection
| Year | Citations | |
|---|---|---|
Page 1
Page 1